Oruka Therapeutics
Healthcare & Life Sci
Company overview
Oruka Therapeutics is a clinical-stage biopharmaceutical company. It develops monoclonal antibody therapeutics for inflammatory diseases. Its lead programs, ORKA-001 and ORKA-002, are designed to block cytokines that play key roles in psoriasis.
Oruka trades on Nasdaq under the ticker ORKA and is headquartered in Menlo Park, California. It employs approximately 28 full-time staff, so anyone joining works on a small team helping push ORKA-001 and ORKA-002 through clinical development. Historically, the median salary is ~$153,500.
- Industry
- Healthcare & Life Sci
- Headquarters
- Waltham, United States